Modern medical practice rests on a solid foundation of scientific research and strict regulatory frameworks for drug safety. However, concerns sometimes arise about the safety and effectiveness of certain drugs.
One such case is the case of the drug Zantac, the well-known antidyspeptic widely used to treat severe acid-protecting gingivitis and other gastrointestinal diseases. In recent years, thousands of former Zantac users have filed lawsuits linking the drug to cancer. Many of these lawsuits have been filed against Sanofi, the French pharmaceutical giant that manufactured and sold Zantac.
According to Bloomberg reports, Sanofi has agreed to pay about $100 million to about 4.000 plaintiffs in order to settle the damages lawsuits. The settlement provides for the payment of approximately $25.000 to each user who suffered complications from the drug.
This case highlights the importance of recognizing the potential risks to public health and the importance of justice in compensating those who may have been harmed.
In closing, I list some possible sources:
- Bloomberg: Link to the article
- American Medical Association: Link to website
- Center for Disease Control and Prevention (CDC): Link to website
From the journalistic team of Greek News and Radio FL
photo https://tovima.gr
